| Chemical | Toxicity Endpoint Type | Endpoint Description | Endpoint Value | Sample Size | Life Cycle Stage | Study Duration | Specific Location | Type |
|---|---|---|---|---|---|---|---|---|
| CYANOFENPHOS | TOX-Non-Repro-Sublethal - whole animal | incidence of delayed neurotoxicity signs | increased | 10 | Juvenile | 90 days | laboratory | Toxicity Factor Datasets |
| CYANOFENPHOS | TOX-MORT - dose-response data | mortality versus controls) | increased (30% @ 10 mg leptophos/kg/d; 10% @ 0.5 mg cyanofenphos/kg/d; 0% @ 1.0 mg cyanofenphos/kg/d; 20% @ 2.0 mg cyanofenphos/kg/d ;60% @ 4.0 mg cyanofenphos/kg/d; 100% @ 8.0 mg cyanofenphos/kg/d | 10 | Juvenile | 90 days | laboratory | Toxicity Factor Datasets |
| CYANOFENPHOS | TOX-Non-Repro-Sublethal - whole animal | bw versus controls | decreased @ 2.0, 4.0 mg/kg/d | 10 | Juvenile | 90 days | laboratory | Toxicity Factor Datasets |
| CYANOFENPHOS | TOX-Non-Repro-Sublethal - organ/system effects | incidence of histological lesions in axons and myelin sheaths | increased @ 2.0, or 4.0 mg cyanofen/kg/d, 10 mg leptophos/kg/d. | 10 | Juvenile | 90 days | laboratory | Toxicity Factor Datasets |
